Top Ten Holdings

Summary by AI BETAClose X

Hansa Investment Company Limited has provided a monthly update on its investment holdings as of April 30, 2026, with the iShares Core S&P 500 UCITS ETF representing the largest holding at 10.7% of gross assets. Other significant investments include the Life Cycle US Equity Fund at 5.0% and the Polar Capital Global Technology Fund at 3.9%. The company's top ten holdings collectively account for 38.1% of its assets, with cash and liquidity funds making up 16.9%. The deployment of cash from the sale of Wilson Sons continues quarterly, with the second tranche deployed in March 2026.

Disclaimer*

Hansa Investment Company Limited
01 May 2026
 

Hansa Investment Company Limited

 

At close of business on 30th April 2026 the Company held the following investments with a value greater than 5% of gross assets or were at least the 10 largest holdings, a declaration of which is required quarterly under the Listing Rules; however Hansa Investment Company Limited has decided to declare this information on a monthly basis:

 


%



iShares Core S&P 500 UCITS ETF

10.7

Life Cycle US Equity Fund - UCITS

5.0

Polar Capital Global Technology Fund

3.9

Helikon Long Short Equity Fund ICAV

3.3

iShares Core MSCI Europe UCITS ETF

3.0

iShares Expanded Tech Sector ETF

2.7

Schroder ISF Asian Total Return

2.7

Findlay Park American Fund

2.4

BlackRock Strategic Equity Hedge Fund

2.2

Schroder ISF Global Recovery

2.2

Total

38.1

Cash (including liquidity funds)*

16.9

 

*The cash from the sale of Wilson Sons is being deployed on a quarterly basis over the course of one year, although the Investment Advisor retains the ability to vary this if market opportunities arise. The first tranche of cash was deployed at the end of December 2025. The second tranche was deployed at the end of March 2026.

 

Hansa Capital Partners LLP

Additional Administrative Services Provider to Hansa Investment Company Limited

020 7647 5750

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings